摘要
目的研究P-糖蛋白(P.gP)在人膀胱癌耐阿霉素细胞株(pumc-91/ADM)及不耐药膀胱癌细胞株(pumc-91)中的差异表达。方法横断面研究,采用阿霉素浓度梯度诱导法从人膀胱移行细胞癌puree-91建立人膀胱癌多药耐药细胞系pumc-91/ADM,通过SYBRGreenI实时荧光定量PCR(qRT-PCR)检测pumc-91/ADM和pumc-91细胞株中P—gPmRNA的表达情况,利用蛋白免疫印迹法(WesternBlot)对两种细胞中P-gP蛋白的表达进行半定量分析,同时采用免疫细胞化学技术对两种细胞中P-gP蛋白的表达进行定位及半定量分析,实验数据均使用独立样本的t检验进行分析。结果qRT-PCR结果显示,与pumc-91细胞相比,P-gPmRNA在pumc-91/ADM细胞中的表达水平上调了约7.74倍(t=11.97,P〈0.05);利用Image J软件分析Westernblot条带光密度比值,P-gP蛋白在pumc-91/ADM中的表达量(1.393±0.328)明显高于pumc-91(0.953±0.250)(t=4.35,P〈0.05);通过免疫细胞化学染色发现,P-gP在两种细胞的胞膜和胞浆均有表达,且在pumc-91/ADM中的表达量明显高于pumc-91(t=11.41,P〈0.05),差异均有统计学意义。结论P-gP在人膀胱癌耐阿霉素细胞株(pumc-91/ADM)中表达水平比其在不耐药膀胱癌细胞株(pumc-91)中表达水平显著上调。
Objective The generation of drug resistance often leads to the failure of the bladder cancer chemotherapy. P-glycoprotein (P-gp) is an ATP-dependent drug efflux pump linked to development of muhidrug resistance in cancer cells. The laboratory has successfully established adriamycin-resistant human bladder cancer cell line (pumc-91/ADM) from its parental cell line (pumc-91). According to the drug resistant spectrum analysis, pumc-91/ADM cell line exhibited the characteristics of multi-drug resistance. However, the expression of P-gp in two cell lines was still unknown. In this paper, there was a comparison between pumc-91/ADM and puree-91 about the differential expression of P-gp. Methods To determine the expression and location of P-gp in pumc-91 and pumc-91/ADM, qRT-PCR, Western blot and immunocytochemistry were applied in the experiment, qRT-PCR was implemented to research the expression of P-gp mRNA in two cell lines (pumc-91/ADM and pumc-91 ). Western blot was adopted to investigate the expression of P-gp protein in pumc-91 and pumc-91/ADM cell lines. Immunocytochemistry technique was used to explore the cellular location of P-gp and affirm its expression in two cell lines visually. Student's t-test was employed for statistical analysis and P 〈 0.05 was considered statistically significant. Results qRT-PCR analysis revealed that the expression of P-gp mRNA was upregulated in drug-resistant cell line pumc-91/ ADM compared to parental cell line pumc-91. To normalize for differences in the amount of total RNA, GAPDH was selected as an endogenous RNA control. Compared with pumc-91, the expression of P-gp mRNA was upregulated 7.74 fold in pumc-91/ADM (t = 11.97, P 〈 0. 05 ). Consistent with the qRT-PCR result, Western blot confirmed the protein of P-gp expressed differentially in two cell lines. The expression of P-gp protein was significantly increased in pumc-91/ADM compared to pumc-91. According to the results, the differences between pumc-91 and pume-91/ADM had statistical significance (t = 4.35, P〈0.05). Immunocytochemical analysis results demonstrated that P-gp was not only located in cell membrane but also in cytoplasm of the two cell lines. The expression of P-gp in pumc-91/ADM increased distinctly. The difference was statistically significant ( t = 11.41, P 〈 0. 05 ). Conclusion Compared with pumc-91, the expression of P-gp in pumc-9l/ADM was significantly upregulated.
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2015年第4期277-280,共4页
Chinese Journal of Laboratory Medicine
基金
北京市自然科学基金(7122086)
关键词
膀胱肿瘤
癌
移行细胞
细胞系
肿瘤
P-糖蛋白
Urinary bladder neoplasms
Carcinoma, transitional cell
Cell line, tumor
R Glycoprotein